Tatva Chintan Pharma Chem Limited IPO

Mainboard

Chemicals

Listed On: Jul 29, 2021 at ₹ 2111.85(NSE)

₹ 14079 /13 Shares

Check Allotment

Price Summary

Last Closing

825.00 (-23.82%)

52 Week High

1,650.85

52 Week Low

788.50

Last Update

25-Nov-2024 3:30 PM

IPO Details

16 Jul, 2021

Open Date

20 Jul, 2021

Close Date

26 Jul, 2021

Allotment Date

29 Jul, 2021

Listing Date

Issue Price

₹1073-1083 per equity share

Face Value

₹10 Per Equity Share

Listing at Group

BSE, NSE

Registrar

Link Intime India Private Ltd

List Price

2111.85(NSE)

Listing Date

2021-07-29

Market Lot

13 Shares (₹14,079/-)

Lead Manager

ICICI Securities Limited, JM Financial Consultants Private Limited

Issue Size

500 Cr(225 Cr Fresh Issue + 275 Cr Offer for Sale)

Retail Portion

35%

Subscription

182.04 times

IPO Docs

DRHP RHP

IPO Subscription Details

As on	QIB	NII	Retail	Total
Shares Offered / Reserved	9,31,966	6,98,975	16,30,941	32,61,882
Day 1 - 16-07-20 05:00 PM	0.51 x	1.13	8.25 x	4.51 x
Day 2 - 19-07-20 05:00 PM	1.97 x	12.21	23.74 x	15.05 x
Day 3 - 20-07-20 05:00 PM	186.96 x	516.99	35.67 x	182.04 x

Total No. of Applications: 3244130 (Approx)

Retail Subscription on the basis of Applications: 26.10 times

Valuations

Earnings Per Share (EPS)

₹23.64/-

P/E Ratio

45.80

RoNW

31.49%

Net Asset Value (NAV) - As on 31.03.21

₹82.62

Company Financials All values are in ₹ Cr.

	31-Mar-21	31-Mar-20	31-Mar-19	31-Mar-18
Assets	314.80	248.94	187.51	143.72
Revenue	306.29	264.62	206.8	137.29
Profit After Tax	52.26	37.79	20.54	12.29

About The Company

Incorporated in 1996, Tatva Chintan Pharma Chem Limited is a chemical manufacturing company that manufactures structure directing agents (SDAs), phase transfer catalyst (PTCs), pharmaceutical and agrochemical intermediates, and other specialty chemicals. It is among the largest manufacturer of SDAs for zeolites in India.

The company serves customers across industries i.e. automotive, petroleum, agrochemicals, dyes and pigments, paints and coatings, pharmaceutical, personal care, and others. Its products are not only sold in India but also export to 25+ countries all over the world such as the USA, Germany, South Africa, China, and the UK. In FY 2020, total export contributed to 76% of total revenue from operations.

Merck, Bayer AG, Ipox Chemicals, Laurus labs, Navin Fluorine International Limited, Atul Limited, Otsuka Chemicals, SRF Limited, Hawks Chemical Company, Firmenich Aromatics Prod Pvt Ltd, and Divi's laboratories are a few of customers of the company. Currently, it has two manufacturing facilities at Ankleshwar and Dahej in Gujarat.

	P/B Ratio	P/E Ratio	RoNW	Net Worth
Tatva Chintan Pharma Chem Limited	13.11	45.80	31.49%	306.29 Cr
Aarti Industries Limited	7.79	28.46	15.05%	4,506.80 Cr
Navin Fluorine International Limited	11.62	73.63	18.13%	1,258.43 Cr
Alkyl Amines	9.48	26.40	37.27%	1,249.38 Cr
Vinati Organics	12.88	73.58	17.45%	980.10 Cr
Fine Organics Industries	12.64	78.47	15.56%	294.41 Cr

IPO - Ratings

Axis Capital	Neutral
Capital Market	Neutral
Choice Broking Ltd	Subscribe
KR Choksey	Subscribe
Sharekhan Limited	Neutral

- Promoter(s)

Pre Issue Share Holding: 100%

Post Issue Share Holding: 79.17%

Company Promoter(s)

Ajaykumar Mansukhalal Patel
Chintan Nitinkumar Shah
Shekhar Rasiklal Somani

IPO - Issue Objectives

Funding capital expenditures requirements for expansion of Dahej manufacturing facility.
Funding capital expenditures requirements to upgrade R&D facilities in Vadodara.
To meet general corporate purposes.

IPO - Anchor Investors

Tatva Chintan Pharma Chem mobilises Rs 150 crore from anchor investors ahead of IPO

Marquee global investors who participated in the anchor book were Goldman Sachs, HSBC Global, Abu Dhabi Investment Authority, Aberdeen Standard Asia, and Nomura.

Axis MF, Aditya Birla Sun Life, Nippon Life, SBI Life Insurance, SBI MF, ICICI Prudential, and HDFC Trustee are among domestic investors invested in the specialty company through anchor book.

IPO - FAQs

Ans. Tatva Chintan Pharma Chem Limited IPO is a Mainboard IPO. The issue is priced at ₹1073-1083 per equity share. The minimum order quantity is 13 Shares. The IPO opens on Jul 16, 2021, and closes on Jul 20, 2021. Link Intime India Private Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.

Ans. The Tatva Chintan Pharma Chem Limited IPO opens on Jul 16, 2021 and closes on Jul 20, 2021.

Ans. The size of Tatva Chintan Pharma Chem Limited IPO is 500 Cr(225 Cr Fresh Issue + 275 Cr Offer for Sale).

Ans. The IPO price band is set between ₹1073-1083 per equity share.

Ans. To apply for Tatva Chintan Pharma Chem Limited IPO IPO, follow the steps given below:

- Open the IPO Ji App or Website
- Find Tatva Chintan Pharma Chem Limited IPO in the List of IPOs
- Press "Apply" Button
- Select Your Demat Account
- Select Your Shares Quantity and Submit
- Track Your IPO Status

Ans. The share allotment date of Tatva Chintan Pharma Chem Limited IPO is Jul 26, 2021.

Ans. The Tatva Chintan Pharma Chem Limited IPO will be listed on Jul 29, 2021.

Ans. Follow the steps to check the allotment status for Tatva Chintan Pharma Chem Limited IPO here.